IN2014MN01427A - - Google Patents

Download PDF

Info

Publication number
IN2014MN01427A
IN2014MN01427A IN1427MUN2014A IN2014MN01427A IN 2014MN01427 A IN2014MN01427 A IN 2014MN01427A IN 1427MUN2014 A IN1427MUN2014 A IN 1427MUN2014A IN 2014MN01427 A IN2014MN01427 A IN 2014MN01427A
Authority
IN
India
Prior art keywords
liquid composition
diluting
manufacturing
tea juice
beverage obtainable
Prior art date
Application number
Inventor
Alistair David Smith
Loyd Wix
Shi Qiu Zhang
Original Assignee
Unilever Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Plc filed Critical Unilever Plc
Publication of IN2014MN01427A publication Critical patent/IN2014MN01427A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23FCOFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00Tea; Tea substitutes; Preparations thereof
    • A23F3/16Tea extraction; Tea extracts; Treating tea extract; Making instant tea
    • A23F3/163Liquid or semi-liquid tea extract preparations, e.g. gels, liquid extracts in solid capsules
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23FCOFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00Tea; Tea substitutes; Preparations thereof
    • A23F3/06Treating tea before extraction; Preparations produced thereby

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Dispersion Chemistry (AREA)
  • Tea And Coffee (AREA)
  • Non-Alcoholic Beverages (AREA)

Abstract

A liquid composition comprising expressed tea juice and from 5 to 30wt % of exogenous biopolymer is provided. A beverage obtainable by diluting the liquid composition and a process for manufacturing the liquid composition are also provided.
IN1427MUN2014 2012-01-27 2013-01-18 IN2014MN01427A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12152821 2012-01-27
PCT/EP2013/050906 WO2013110550A1 (en) 2012-01-27 2013-01-18 Liquid tea composition

Publications (1)

Publication Number Publication Date
IN2014MN01427A true IN2014MN01427A (en) 2015-06-12

Family

ID=47563518

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1427MUN2014 IN2014MN01427A (en) 2012-01-27 2013-01-18

Country Status (7)

Country Link
EP (1) EP2806748B1 (en)
CN (1) CN104080351A (en)
EA (1) EA025556B1 (en)
ES (1) ES2560438T3 (en)
IN (1) IN2014MN01427A (en)
PL (1) PL2806748T3 (en)
WO (1) WO2013110550A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6821536B2 (en) * 2002-11-22 2004-11-23 Quercegen Holdings Llc Antioxidative compositions
JP5415758B2 (en) * 2005-07-22 2014-02-12 ユニリーバー・ナームローゼ・ベンノートシヤープ Beverage precursor and method for producing the same
JP4838752B2 (en) * 2006-11-13 2011-12-14 花王株式会社 Container drink
TWI412326B (en) * 2006-11-13 2013-10-21 Kao Corp Containers
WO2009059925A1 (en) * 2007-11-05 2009-05-14 Unilever Plc Process for manufacturing tea products and products obtainable thereby

Also Published As

Publication number Publication date
PL2806748T3 (en) 2016-06-30
CN104080351A (en) 2014-10-01
EA025556B1 (en) 2017-01-30
EP2806748A1 (en) 2014-12-03
WO2013110550A1 (en) 2013-08-01
ES2560438T3 (en) 2016-02-19
EP2806748B1 (en) 2015-12-02
EA201491430A1 (en) 2015-04-30

Similar Documents

Publication Publication Date Title
WO2014124087A8 (en) Induced pluripotent cell-derived oligodendrocyte progenitor cells for the treatment of myelin disorders
WO2013181585A3 (en) Methods related to adalimumab
EP2938616A4 (en) The present invention relates to process for the preparation of tofacitinib and intermediates thereof.
IN2015KN00262A (en)
WO2012109210A3 (en) Apparatuses and methods for the simultaneous production of microfibers and nanofibers
IL232553A0 (en) Improved process for the manufacture of alcoholic beverages and products produced by such process
MX2012013324A (en) Substituted 5-fluoro-1h-pyrazolopyridines and use thereof.
AU344878S (en) Table top
MX2015001203A (en) Enzymes.
MX2015006915A (en) Preparation of a stable beverage.
IN2015KN00323A (en)
IN2012DE00849A (en)
AU342089S (en) Table top
MX347882B (en) Improved process for preparing (3e,7e)-homofarnesol.
EA201790153A2 (en) ENZYME
WO2013181586A3 (en) Methods related to bevacizumab
MX2014002446A (en) Novel substituted cyclohexane compounds.
WO2014060640A8 (en) A process for the preparation of ospemifene
MX2013002480A (en) Stemware for sparkling beverages and method for the production thereof.
NZ628451A (en) Dehydrated plant-derived products and methods for making the same
MY165744A (en) Process for the preparation of trisilylamine from monochlorosilane and ammonia
WO2013188344A3 (en) Laundry soap bars
WO2014178064A3 (en) "an improved process for the preparation of fluvoxamine maleate"
WO2014102759A3 (en) Process for the preparation of dasatinib and its intermediates
IN2014MN01427A (en)